Nuria Valls-Sola
Reus, CT 43204, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: April 15, 2026
An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study.
Journal: Frontiers in neurology
Published: February 21, 2025
Efficacy of cognitive rehabilitation in cognition and brain networks: A randomised clinical trial in patients with multiple sclerosis.
Journal: NeuroImage. Clinical
Published: November 19, 2024
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Journal: Journal of clinical medicine
Published: September 15, 2023
The role of specialist nurses in detecting spasticity and related symptoms in multiple sclerosis.
Journal: Journal of clinical nursing
Published: November 11, 2021
Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis.
Journal: Journal of personalized medicine
Published: September 30, 2021
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 12, 2021
Impact of Cognitive Reserve and Structural Connectivity on Cognitive Performance in Multiple Sclerosis.
Journal: Frontiers in neurology
Published: July 09, 2020
Last Updated: 09/26/2026